TY - JOUR
T1 - European Network to Advance Best Practices and Technology on Medication Adherence
T2 - Mission Statement
AU - van Boven, Job Fm
AU - Tsiligianni, Ioanna
AU - Potočnjak, Ines
AU - Mihajlović, Jovan
AU - Dima, Alexandra L
AU - Nabergoj Makovec, Urska
AU - Ágh, Tamás
AU - Kardas, Prezmyslaw
AU - Ghiciuc, Cristina Mihaela
AU - Petrova, Guenka
AU - Bitterman, Noemi
AU - Kamberi, Fatjona
AU - Culig, Josip
AU - Wettermark, Björn
AU - European Network to Advance Best Practices and Technology on Medication AdherencE (ENABLE)
N1 - Copyright © 2021 van Boven, Tsiligianni, Potočnjak, Mihajlović, Dima, Nabergoj Makovec, Ágh, Kardas, Ghiciuc, Petrova, Bitterman, Kamberi, Culig, Wettermark and European Network to Advance Best Practices and Technology on Medication AdherencE (ENABLE).
PY - 2021/10/11
Y1 - 2021/10/11
N2 - Medication non-adherence is associated with almost 200,000 deaths annually and €80-125 billion in the European Union. Novel technological advances (smart pill bottles, digital inhalers and spacers, electronic pill blisters, e-injection pens, e-Health applications, big data) could help managing non-adherence. Healthcare professionals seem however inadequately informed about non-adherence, availability of technological solutions in daily practice is limited, and collaborative efforts to push forward their implementation are scarce. The European Network to Advance Best practices and technoLogy on medication adherencE (ENABLE, COST Action 19132) aims to 1) raise awareness of adherence enhancing solutions, 2) foster knowledge on medication adherence, 3) accelerate clinical application of novel technologies and 4) work collaboratively towards economically viable policy, and implementation of adherence enhancing technology across healthcare systems.
AB - Medication non-adherence is associated with almost 200,000 deaths annually and €80-125 billion in the European Union. Novel technological advances (smart pill bottles, digital inhalers and spacers, electronic pill blisters, e-injection pens, e-Health applications, big data) could help managing non-adherence. Healthcare professionals seem however inadequately informed about non-adherence, availability of technological solutions in daily practice is limited, and collaborative efforts to push forward their implementation are scarce. The European Network to Advance Best practices and technoLogy on medication adherencE (ENABLE, COST Action 19132) aims to 1) raise awareness of adherence enhancing solutions, 2) foster knowledge on medication adherence, 3) accelerate clinical application of novel technologies and 4) work collaboratively towards economically viable policy, and implementation of adherence enhancing technology across healthcare systems.
KW - MEDICATION ADHERENCE
KW - digital health
KW - EHEALTH
KW - TECHNOLOGY
KW - COST Action
KW - ELECTRONIC HEALTH RECORD
U2 - 10.3389/fphar.2021.748702
DO - 10.3389/fphar.2021.748702
M3 - Article
C2 - 34707502
SN - 1663-9812
VL - 12
JO - Frontiers in Pharmacology
JF - Frontiers in Pharmacology
M1 - 748702
ER -